Screening & Prevention Module Spring 2025
All 51³Ô¹Ïmembers are invited to participate in the Screening & Prevention Module of the Clinical Benchmarking Program. This module will assess whether randomly selected medical charts contain appropriate documentation of allergies and influenza vaccination, as well as screening for tobacco/nicotine use, unhealthy drug use, unhealthy alcohol use, and depression.
Each health center will review 25 randomly selected charts that meet the following criteria:
- include at least one primary care visit between Sept 1, 2024 and February 28, 2025, AND
- patient is 18 years of age or older, AND
- WITHOUT an existing diagnosis of depression
For each chart, the reviewer should determine whether six Screening & Prevention Clinical Benchmarks have been appropriately documented using the criteria outlined in the Background/Instructions/Scoring Criteria document. Record your responses on the Chart Review Documentation worksheet and then to the 51³Ô¹ÏResearch Department.
Submit your completed materials by July 11, 2025.
Questions?
Contact:
Mary Hoban, PhD, 51³Ô¹ÏChief Research Officer
Jessica Higgs, MD, 51³Ô¹ÏBenchmarking Committee Chair
About the Clinical Benchmarking Program
A significant part of the 51³Ô¹Ï’s mission is to enhance its members’ ability to advance the health of all students and the campus community. To meet this mission, ACHA, through its Benchmarking Committee, has developed a series of clinical benchmarking tools in response to many institutions’ desire to have a means to benchmark their clinical quality care standards. The benchmarking measures have been based on input from members, other national and governmental health care organizations, and evidence-based literature.
Goals of the Clinical Benchmarking Program
- To identify areas and means of performance improvement
- To understand the quality of care provided by member institutions for college students
- To find areas of potential education and focus for 51³Ô¹Ïinitiatives to improve quality of care in college health
For 51³Ô¹Ïand the Clinical Benchmarking Program participants to compare quality provided by member organizations against community and national standards.
